查看購物車
  • English
封面
市場調查報告書
商品編碼
1914618

足踝醫療設備市場－全球產業規模、佔有率、趨勢、機會及預測（依產品類型、手術、應用、最終用戶、地區及競爭格局分類），2021-2031年

Foot & Ankle Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type, By Procedure, By Application, By End User, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球足踝醫療設備市場預計將從2025年的54.9億美元成長到2031年的77.4億美元，複合年成長率（CAGR）為5.89%。該市場涵蓋整形外科植入、義肢和外矯正器具系統，旨在治療肌肉骨骼疾病、創傷和下肢畸形。這一成長主要受全球人口老化（骨關節炎發病率上升）以及需要手術修復的運動相關損傷增加所驅動。此外，糖尿病併發症盛行率的上升也顯著增加了對專用重組和減壓裝置的需求。根據國際糖尿病聯盟（IDF）2024年的數據，全球約有5.89億成年人患有糖尿病，凸顯了有效糖尿病足管理方案的重要性。

市場概覽
預測期 2027-2031
市場規模：2025年 54.9億美元
市場規模：2031年 77.4億美元
複合年成長率：2026-2031年 5.89%
成長最快的細分市場 關節移植
最大的市場 北美洲

然而，植入手術的高昂費用以及產品核可所需的嚴格監管流程阻礙了市場擴張。這些經濟和行政障礙會限制患者獲得創新治療方法的機會，並減緩醫療技術的商業化進程，尤其是在對成本高度敏感的發展中地區。因此，儘管臨床對先進醫療設備的需求依然旺盛，但這些障礙限制了新解決方案在全球醫療系統中的引進和應用速度。

市場促進因素

糖尿病足併發症發生率的不斷上升是推動全球足踝醫療設備市場擴張的主要因素。高血糖症常導致周邊神經病變和血管疾病，顯著增加足部潰瘍、夏科氏足以及最終下肢截肢的風險。這些嚴重的併發症需要使用專門的內固定裝置、重組植入和外部矯正器具系統來維持患者的活動能力並防止截肢。美國國立衛生研究院於2025年4月發表的一項題為《下肢大截肢的機構差異》的研究顯示，在確診糖尿病足潰瘍後僅一年內，就有3.8%的患者接受了下肢大截肢手術。這凸顯了臨床上迫切需要先進的治療設備來有效應對這種複雜的疾病。

市場成長得益於快速的產品創新和策略核准，製造商正致力於開發用於軟組織修復和踝關節不穩定的先進解決方案。該行業日益關注微創手術 (MIS) 系統和符合人體解剖結構的鋼板技術，以改善患者預後並縮短復原時間。例如，史密斯醫療器材公司 (Smith & Nephew) 於 2025 年 2 月發布的 2024 年年度報告指出，該公司推出了 ULTRABRACE 系統和 ULTRABRIDGE 系統等新型手術解決方案，這些方案專為踝關節不穩和跟腱重組設計。產業整合的加劇進一步強化了這項技術進步趨勢。例如，捷邁生物 (Zimmer Biomet) 宣布將於 2025 年達成最終協議，收購 Paragon 28，以積極拓展其在快速成長的足踝領域的業務。

市場挑戰

全球足踝醫療設備市場的財務永續性正受到手術報銷率持續下降的直接威脅。隨著醫療系統尋求削減開支，整形外科手術支付模式的縮減為高價值植入技術的應用帶來了挑戰。當醫療機構面臨複雜手術報銷額下降時，他們被迫優先考慮標準治療方法，而非更新、更昂貴的器械選擇。這種財務壓力限制了先進踝關節解決方案的市場准入，並由於投資回報的不確定性，阻礙了製造商在創新方面進行重大投資。

據美國足病醫學協會稱，美國醫療保險和醫療補助服務中心已最終確定，2025年醫生診療費的轉換係數將年減約2.83%。這種系統性的醫師診療費下降正從根本上削弱下肢專科醫療機構的財務基礎。因此，預算限制導致患者難以獲得有效的重組治療，減緩了整個踝關節器械市場的收入成長，並阻礙了整體市場的擴張。

市場趨勢

隨著醫療系統優先考慮成本效益高的當日手術環境，踝關節手術轉移到門診手術中心 (ASC) 的轉移正在從根本上改變市場結構。這種運作模式的轉變推動了對無菌預包裝、高效植入系統的需求，這些系統能夠減少門診手術的圍手術期時間和庫存負擔。器械製造商正在加速調整策略，以擺脫對停滯不前的醫院手術量的依賴，並抓住這些專業機構不斷成長的病例量。 Paragon 28 的案例說明了這種轉變所帶來的財務影響。在其 2025 年 1 月發布的「未經審核收入」新聞稿中，該公司報告稱，2024 會計年度全年收入約為 2.56 億美元（同比成長 18%），這一顯著成長主要得益於其專業產品組合在快速成長的門診手術中心市場中的強勁需求。

同時，3D列印特異性植入的廣泛應用正在革新外科手術規劃，其製造的植入物具有高孔隙率和解剖結構相容性，能夠促進骨整合。這項技術能夠生產傳統製造過程無法實現的複雜幾何形狀，因此在全踝置換術和需要保留骨骼的大規模重組手術中尤其有利。整合了積層製造的公司正在市場上實現顯著的收入成長。例如，Enobis在2025年2月發布的「2024年第四季及全年業績報告」中指出，其重建部門的營收成長了59%，這主要得益於其策略性地整合了從LimaCorporate收購的先進3D列印技術。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章 全球足踝醫療設備市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依產品類型（固定裝置、人工關節、關節移植、軟組織整形外科裝置、矯正器具及支撐裝置）
    • 透過手術（骨折修復、截骨、固定或其他）
    • 依應用領域（創傷/微骨折、韌帶損傷、類風濕性關節炎/骨關節炎、糖尿病足病變、其他）
    • 依最終使用者（醫院、整形外科診所、門診手術中心、復健中心）分類
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

6. 北美足踝醫療設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

7. 歐洲足踝醫療設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

8. 亞太地區足踝醫療設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

9. 中東和非洲足踝醫療設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美足踝醫療設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進要素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 最新進展

第13章 全球足踝醫療設備市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的可能性
  • 供應商電力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Stryker Corporation
  • Zimmer Biomet Holdings, Inc.
  • Smith & Nephew plc
  • DePuy Synthes
  • Arthrex, Inc.
  • Wright Medical Group NV
  • Medtronic plc
  • CONMED Corporation
  • Colfax Corporation
  • Integra LifeSciences Corporation

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 7342

The Global Foot & Ankle Devices Market is projected to rise from a valuation of USD 5.49 Billion in 2025 to USD 7.74 Billion by 2031, achieving a CAGR of 5.89%. This market encompasses orthopedic implants, prosthetics, and external bracing systems designed to address musculoskeletal disorders, trauma, and lower extremity deformities. The growth is largely fueled by an aging global population susceptible to osteoarthritis and a rising frequency of sports-related injuries that necessitate surgical repair. Furthermore, the increasing prevalence of diabetes-related complications creates substantial demand for specialized reconstructive and offloading devices. Data from the International Diabetes Federation in 2024 indicates that approximately 589 million adults were living with diabetes worldwide, underscoring the critical necessity for effective diabetic foot management solutions.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 5.49 Billion
Market Size 2031USD 7.74 Billion
CAGR 2026-20315.89%
Fastest Growing SegmentJoint Implants
Largest MarketNorth America

However, the market's expansion is hindered by the high costs associated with implant procedures and the rigorous regulatory processes required for product approval. These financial and bureaucratic barriers can restrict patient access to innovative therapies and slow the commercialization of medical technologies, particularly in developing regions where cost sensitivity is high. Consequently, while the clinical need for advanced devices remains strong, these hurdles limit the speed at which new solutions can be adopted and distributed across global healthcare systems.

Market Driver

The increasing incidence of diabetes-related foot complications acts as a primary driver for the expansion of the Global Foot & Ankle Devices Market. Elevated blood sugar levels frequently result in peripheral neuropathy and vascular disease, conditions that significantly heighten the risk of foot ulcers, Charcot foot, and subsequent lower limb amputations. These severe complications demand the use of specialized internal fixation devices, reconstruction implants, and external bracing systems to preserve mobility and prevent limb loss. A study by the National Institutes of Health released in April 2025, titled 'Facility-Level Variation in Major Leg Amputation,' revealed that major leg amputation was performed on 3.8% of patients within just one year of a diabetic foot ulcer diagnosis, highlighting the urgent clinical need for advanced therapeutic devices to manage complex pathologies effectively.

Market growth is further accelerated by rapid product innovation and strategic approvals, as manufacturers create sophisticated solutions for soft tissue repair and ankle instability. There is a growing industry focus on minimally invasive surgery (MIS) systems and anatomically contoured plating technologies aimed at improving patient outcomes and shortening recovery times. For instance, Smith+Nephew's 'Annual Report 2024,' published in February 2025, noted the launch of new procedure solutions such as the ULTRABRACE and ULTRABRIDGE systems designed for ankle instability and Achilles reconstruction. This trend toward technological advancement is bolstered by significant industry consolidation, as seen in Zimmer Biomet's 2025 announcement of a definitive agreement to acquire Paragon 28 to aggressively expand its footprint in the high-growth foot and ankle segment.

Market Challenge

The financial sustainability of the Global Foot & Ankle Devices Market is directly challenged by ongoing reductions in reimbursement rates for surgical procedures. As healthcare systems aim to reduce expenditures, the declining payment models for orthopedic interventions create a difficult environment for the adoption of premium implant technologies. When providers encounter lower compensation for complex surgeries, they are often forced to prioritize standard treatments over newer, more expensive device options. This financial pressure restricts the entry of advanced foot and ankle solutions into the market and discourages manufacturers from investing heavily in innovation due to uncertain returns on investment.

According to the American Podiatric Medical Association in 2025, the Centers for Medicare and Medicaid Services finalized a conversion factor reduction of approximately 2.83 percent compared to the previous year. This systematic decrease in physician payment rates fundamentally strains the operational economics of medical practices specializing in lower extremity care. Consequently, these budgetary constraints limit patient access to effective reconstructive therapies and slow the overall revenue trajectory of the foot and ankle devices sector, hindering broader market growth.

Market Trends

The shift of foot and ankle procedures to Ambulatory Surgical Centers (ASCs) is fundamentally reshaping the market as healthcare systems prioritize cost-effective, same-day surgical environments. This operational transition drives demand for sterile-packaged, streamlined implant systems that reduce turnover time and inventory burdens in outpatient settings. Device manufacturers are increasingly adapting their strategies to capture expanding caseloads in these specialized facilities, moving away from reliance on stagnant hospital volumes. The financial impact of this migration is illustrated by Paragon 28, which reported in its January 2025 'Preliminary Unaudited Revenue' press release a full-year 2024 revenue of approximately $256 million, an 18% increase largely driven by the robust adoption of its specialized portfolio in the fast-growing ASC space.

Simultaneously, the proliferation of 3D-printed patient-specific implants is revolutionizing surgical planning by enabling the creation of highly porous, anatomically matched devices that enhance osseointegration. This technology allows for the fabrication of complex geometries that traditional manufacturing cannot achieve, offering specific benefits for total ankle replacements and large reconstructive cases where bone preservation is critical. The market is seeing a significant revenue surge for organizations that have integrated additive manufacturing; for example, Enovis reported in its 'Fourth Quarter and Full Year 2024 Results' in February 2025 that its Reconstructive segment achieved a 59% reported revenue increase, a metric significantly bolstered by the strategic integration of advanced 3D-printing technologies acquired from LimaCorporate.

Key Market Players

  • Stryker Corporation
  • Zimmer Biomet Holdings, Inc.
  • Smith & Nephew plc
  • DePuy Synthes
  • Arthrex, Inc.
  • Wright Medical Group N.V.
  • Medtronic plc
  • CONMED Corporation
  • Colfax Corporation
  • Integra LifeSciences Corporation

Report Scope

In this report, the Global Foot & Ankle Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Foot & Ankle Devices Market, By Product Type

  • Fixation Devices
  • Prosthesis
  • Joint Implants
  • Soft Tissue Orthopedic Devices
  • Bracing & Support Devices

Foot & Ankle Devices Market, By Procedure

  • Fracture Repair
  • Osteotomy
  • Fusion Procedures
  • Others

Foot & Ankle Devices Market, By Application

  • Trauma & Hair line Fractures
  • Ligament Injuries
  • Rheumatoid Arthritis & Osteoarthritis
  • Diabetic Foot Diseases
  • Others

Foot & Ankle Devices Market, By End User

  • Hospitals
  • Orthopedic Clinics
  • Ambulatory Surgery Centers
  • Rehabilitation Centers

Foot & Ankle Devices Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Foot & Ankle Devices Market.

Available Customizations:

Global Foot & Ankle Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Foot & Ankle Devices Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product Type (Fixation Devices, Prosthesis, Joint Implants, Soft Tissue Orthopedic Devices, Bracing & Support Devices)
    • 5.2.2. By Procedure (Fracture Repair, Osteotomy, Fusion Procedures, Others)
    • 5.2.3. By Application (Trauma & Hair line Fractures, Ligament Injuries, Rheumatoid Arthritis & Osteoarthritis, Diabetic Foot Diseases, Others)
    • 5.2.4. By End User (Hospitals, Orthopedic Clinics, Ambulatory Surgery Centers, Rehabilitation Centers)
    • 5.2.5. By Region
    • 5.2.6. By Company (2025)
  • 5.3. Market Map

6. North America Foot & Ankle Devices Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product Type
    • 6.2.2. By Procedure
    • 6.2.3. By Application
    • 6.2.4. By End User
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Foot & Ankle Devices Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product Type
        • 6.3.1.2.2. By Procedure
        • 6.3.1.2.3. By Application
        • 6.3.1.2.4. By End User
    • 6.3.2. Canada Foot & Ankle Devices Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product Type
        • 6.3.2.2.2. By Procedure
        • 6.3.2.2.3. By Application
        • 6.3.2.2.4. By End User
    • 6.3.3. Mexico Foot & Ankle Devices Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product Type
        • 6.3.3.2.2. By Procedure
        • 6.3.3.2.3. By Application
        • 6.3.3.2.4. By End User

7. Europe Foot & Ankle Devices Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product Type
    • 7.2.2. By Procedure
    • 7.2.3. By Application
    • 7.2.4. By End User
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Foot & Ankle Devices Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product Type
        • 7.3.1.2.2. By Procedure
        • 7.3.1.2.3. By Application
        • 7.3.1.2.4. By End User
    • 7.3.2. France Foot & Ankle Devices Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product Type
        • 7.3.2.2.2. By Procedure
        • 7.3.2.2.3. By Application
        • 7.3.2.2.4. By End User
    • 7.3.3. United Kingdom Foot & Ankle Devices Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product Type
        • 7.3.3.2.2. By Procedure
        • 7.3.3.2.3. By Application
        • 7.3.3.2.4. By End User
    • 7.3.4. Italy Foot & Ankle Devices Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product Type
        • 7.3.4.2.2. By Procedure
        • 7.3.4.2.3. By Application
        • 7.3.4.2.4. By End User
    • 7.3.5. Spain Foot & Ankle Devices Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product Type
        • 7.3.5.2.2. By Procedure
        • 7.3.5.2.3. By Application
        • 7.3.5.2.4. By End User

8. Asia Pacific Foot & Ankle Devices Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product Type
    • 8.2.2. By Procedure
    • 8.2.3. By Application
    • 8.2.4. By End User
    • 8.2.5. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Foot & Ankle Devices Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product Type
        • 8.3.1.2.2. By Procedure
        • 8.3.1.2.3. By Application
        • 8.3.1.2.4. By End User
    • 8.3.2. India Foot & Ankle Devices Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product Type
        • 8.3.2.2.2. By Procedure
        • 8.3.2.2.3. By Application
        • 8.3.2.2.4. By End User
    • 8.3.3. Japan Foot & Ankle Devices Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product Type
        • 8.3.3.2.2. By Procedure
        • 8.3.3.2.3. By Application
        • 8.3.3.2.4. By End User
    • 8.3.4. South Korea Foot & Ankle Devices Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product Type
        • 8.3.4.2.2. By Procedure
        • 8.3.4.2.3. By Application
        • 8.3.4.2.4. By End User
    • 8.3.5. Australia Foot & Ankle Devices Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product Type
        • 8.3.5.2.2. By Procedure
        • 8.3.5.2.3. By Application
        • 8.3.5.2.4. By End User

9. Middle East & Africa Foot & Ankle Devices Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product Type
    • 9.2.2. By Procedure
    • 9.2.3. By Application
    • 9.2.4. By End User
    • 9.2.5. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Foot & Ankle Devices Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product Type
        • 9.3.1.2.2. By Procedure
        • 9.3.1.2.3. By Application
        • 9.3.1.2.4. By End User
    • 9.3.2. UAE Foot & Ankle Devices Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product Type
        • 9.3.2.2.2. By Procedure
        • 9.3.2.2.3. By Application
        • 9.3.2.2.4. By End User
    • 9.3.3. South Africa Foot & Ankle Devices Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product Type
        • 9.3.3.2.2. By Procedure
        • 9.3.3.2.3. By Application
        • 9.3.3.2.4. By End User

10. South America Foot & Ankle Devices Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product Type
    • 10.2.2. By Procedure
    • 10.2.3. By Application
    • 10.2.4. By End User
    • 10.2.5. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Foot & Ankle Devices Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product Type
        • 10.3.1.2.2. By Procedure
        • 10.3.1.2.3. By Application
        • 10.3.1.2.4. By End User
    • 10.3.2. Colombia Foot & Ankle Devices Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product Type
        • 10.3.2.2.2. By Procedure
        • 10.3.2.2.3. By Application
        • 10.3.2.2.4. By End User
    • 10.3.3. Argentina Foot & Ankle Devices Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product Type
        • 10.3.3.2.2. By Procedure
        • 10.3.3.2.3. By Application
        • 10.3.3.2.4. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Foot & Ankle Devices Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Stryker Corporation
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Zimmer Biomet Holdings, Inc.
  • 15.3. Smith & Nephew plc
  • 15.4. DePuy Synthes
  • 15.5. Arthrex, Inc.
  • 15.6. Wright Medical Group N.V.
  • 15.7. Medtronic plc
  • 15.8. CONMED Corporation
  • 15.9. Colfax Corporation
  • 15.10. Integra LifeSciences Corporation

16. Strategic Recommendations

17. About Us & Disclaimer